Export 2730 results:
Author Title Type [ Year(Asc)]
1987
S. R. Nerenstone, Archer, J. I., and Cheson, B. D., “Current status and future directions of clinical trials in chronic lymphocytic leukemia.”, Oncology (Williston Park), vol. 1, no. 8, pp. 31-40, 44, 1987.
P. R. Thomas, Stablein, D. M., Steinberg, S. M., Barkin, J. S., and Nauta, R. J., “The effects of liver directed radiotherapy and chemotherapy on liver function tests and hematological parameters in patients with surgically resected colon cancer: findings from the Gastrointestinal Tumor Study Group.”, Am J Gastroenterol, vol. 82, no. 8, pp. 738-43, 1987.
S. D. Williams, Stablein, D. M., Einhorn, L. H., Muggia, F. M., Weiss, R. B., Donohue, J. P., Paulson, D. F., Brunner, K. W., Jacobs, E. M., and Spaulding, J. T., “Immediate adjuvant chemotherapy versus observation with treatment at relapse in pathological stage II testicular cancer.”, N Engl J Med, vol. 317, no. 23, pp. 1433-8, 1987.
1986
T. C. Hall, Stablein, D., and Steinberg, S. M., “Community practice and cancer clinical trials: II. Detection of recurrences in rectal cancer.”, Hawaii Med J, vol. 45, no. 8, p. 261, 1986.
T. C. Hall and Stablein, D. S., “Community practice and cancer clinical trials: III. Value of platelet and differential counts.”, Hawaii Med J, vol. 45, no. 8, p. 262, 1986.
S. M. Steinberg, Barwick, K. W., and Stablein, D. M., “Importance of tumor pathology and morphology in patients with surgically resected colon cancer. Findings from the Gastrointestinal Tumor Study Group.”, Cancer, vol. 58, no. 6, pp. 1340-5, 1986.
J. D. Boice, Greene, M. H., Killen, J. Y., Ellenberg, S. S., Fraumeni, J. F., Keehn, R. J., McFadden, E., Chen, T. T., and Stablein, D., “Leukemia after adjuvant chemotherapy with semustine (methyl-CCNU)--evidence of a dose-response effect.”, N Engl J Med, vol. 314, no. 2, pp. 119-20, 1986.
P. R. Thomas, Stablein, D. M., Kinzie, J. J., Novak, J. W., Childs, D. S., Knowlton, A. H., and Mittelman, A., “Perineal effects of postoperative treatment for adenocarcinoma of the rectum.”, Int J Radiat Oncol Biol Phys, vol. 12, no. 2, pp. 167-71, 1986.
S. M. Steinberg, Barkin, J. S., Kaplan, R. S., and Stablein, D. M., “Prognostic indicators of colon tumors. The Gastrointestinal Tumor Study Group experience.”, Cancer, vol. 57, no. 9, pp. 1866-70, 1986.
H. O. Douglass, Moertel, C. G., Mayer, R. J., Thomas, P. R., Lindblad, A. S., Mittleman, A., Stablein, D. M., and Bruckner, H. W., “Survival after postoperative combination treatment of rectal cancer.”, N Engl J Med, vol. 315, no. 20, pp. 1294-5, 1986.
P. R. Thomas, Lindblad, A. S., Stablein, D. M., Knowlton, A. H., Bruckner, H. W., Childs, D. S., and Mittelman, A., “Toxicity associated with adjuvant postoperative therapy for adenocarcinoma of the rectum.”, Cancer, vol. 57, no. 6, pp. 1130-4, 1986.
1985
N. H. Dubin, Wolff, M. C., Thomas, C. L., and DiBlasi, M. C., “Prostaglandin production by rat vaginal tissue, in vitro, in response to ethanol, a mild mucosal irritant.”, Toxicol Appl Pharmacol, vol. 78, no. 3, pp. 458-63, 1985.
D. Stablein, “Statistical aspects of intraperitoneal chemotherapy studies.”, Semin Oncol, vol. 12, no. 3 Suppl 4, pp. 121-3, 1985.
D. M. Stablein, “Therapeutic synergism.”, Biometrics, vol. 41, no. 4, pp. 1076-7, 1985.
K. V. Shepard, Levin, B., Karl, R. C., Faintuch, J., DuBrow, R. A., Hagle, M., Cooper, R. M., Beschorner, J., and Stablein, D., “Therapy for metastatic colorectal cancer with hepatic artery infusion chemotherapy using a subcutaneous implanted pump.”, J Clin Oncol, vol. 3, no. 2, pp. 161-9, 1985.
D. M. Stablein and Koutrouvelis, I. A., “A two-sample test sensitive to crossing hazards in uncensored and singly censored data.”, Biometrics, vol. 41, no. 3, pp. 643-52, 1985.
1983
F. P. Smith, Stablein, D., Korsmeyer, S., Neefe, J., Chun, B. K., Woolley, P. V., and Schein, P. S., “Combination chemotherapy for locally advanced pancreatic cancer: equivalence to external beam irradiation and implication for future management.”, J Clin Oncol, vol. 1, no. 7, pp. 413-5, 1983.
D. M. Stablein, Carter, W. H., and Wampler, G. L., “Confidence regions for constrained optima in response-surface experiments.”, Biometrics, vol. 39, no. 3, pp. 759-63, 1983.
1982
W. H. Carter, Wampler, G. L., Stablein, D. M., and Campbell, E. D., “Drug activity and therapeutic synergism in cancer treatment.”, Cancer Res, vol. 42, no. 8, pp. 2963-71, 1982.
H. W. Bruckner, Lokich, J. J., and Stablein, D. M., “Studies of Baker's antifol, methotrexate, and razoxane in advanced gastric cancer: A Gastrointestinal Tumor Study Group Report.”, Cancer Treat Rep, vol. 66, no. 9, pp. 1713-7, 1982.
1981
D. M. Stablein, Carter, W. H., and Novak, J. W., “Analysis of survival data with nonproportional hazard functions.”, Control Clin Trials, vol. 2, no. 2, pp. 149-59, 1981.
S. Zimm, Wampler, G. L., Stablein, D., Hazra, T., and Young, H. F., “Intracerebral metastases in solid-tumor patients: natural history and results of treatment.”, Cancer, vol. 48, no. 2, pp. 384-94, 1981.
R. P. Greenberg, Stablein, D. M., and Becker, D. P., “Noninvasive localization of brain-stem lesions in the cat with multimodality evoked potentials: correlation with human head-injury data.”, J Neurosurg, vol. 54, no. 6, pp. 740-50, 1981.
1980
D. M. Stablein, Miller, J. D., Choi, S. C., and Becker, D. P., “Statistical methods for determining prognosis in severe head injury.”, Neurosurgery, vol. 6, no. 3, pp. 243-8, 1980.
D. M. Stablein, Carter, W. H., and Wampler, G. L., “Survival analysis of drug combinations using a hazards model with time-dependent covariates.”, Biometrics, vol. 36, no. 3, pp. 537-46, 1980.